Press releases and news

Treating chronic pain is one of the greatest medical challenges of our time – and a field that has been waiting for real progress for decades. VERTANICAL was founded with the mission of finally opening up new, effective, and safe treatment options for precisely these patients.
With VER-01, we have reached an important milestone on this path. Here you will find our official press releases, current information, and selected media reports.
Known from
The IndependantThe GuardianOmrForbesFinancial TimesBusiness PunkTwsjThetimesSzSaReutersHandelsblattBusinessinsiderThe IndependantThe GuardianOmrForbesFinancial TimesBusiness PunkTwsjThetimesSzSaReutersHandelsblattBusinessinsider
Vertanical In Faz
21.03.2025
Frankfurter Allgemeine Zeitung spotlights VERTANICAL’s promise in pain therapy
Handelsblatt Berichtet Vertanical Ver 01
17.03.2025
Handelsblatt features VERTANICAL as VER-01 moves toward regulatory approval
Vertanical In Der Times
17.03.2025
The Times: “Cannabis painkiller could replace opioids with no risk of addiction”
German Pain N Palliative Care Days Scaled
14.03.2025
VERTANICAL at the German Pain and Palliative Care Days in Frankfurt
Announces Results Phase3 Trial Ver 01
14.03.2025
VERTANICAL Presents Results of the Phase 3 Study on VER-01
1 2
Trigger Post Popup Open

Contact

For questions and further information, please contact:
pr@vertanical.com
{Date Here}

{Post Title Here}

{Post Full Content Here}
Pressekontakt: